Randomized trial to compare the effect of recombinant human FSH (follitropian alfa) with or without recombinant human LH in women udergoing assisted reproduction treatment

Reproductive BioMedicine Online

Volumn 8, Issue 2, 2004, Pages 175-182

  Marrs, Richard ^a   Meldrum, D ^b   Muasher, S ^c   Schoolcraft, W ^d   Werlin, L ^e   Kelly, Eduardo ^f  

^a California Dental Association   (United States)

^b Reproductive Partners Medical Group   (United States)

^c The Jones Institute for Reproductive Medicine   (United States)

^d Centre for Reproductive Medicine   (United States)

^e Coastal Fertility Center ^*  (United States)

^f EMD SERONO INC   (United States)

Author keywords

Age; Ovarian stimulation; Recombinant FSH; Recombinant LH

Indexed keywords

CHORIONIC GONADOTROPIN; LEUPRORELIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; AGE; ARTICLE; CELL COUNT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; EMBRYO TRANSFER; FEMALE; HEADACHE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; INTRACYTOPLASMIC SPERM INJECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE INFERTILITY; METAPHASE; MULTICENTER STUDY; NIDATION; OOCYTE; OPEN STUDY; OVARY HYPERSTIMULATION; OVULATION INDUCTION; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; TREATMENT INDICATION;

EID: 1142287367     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60513-5     Document Type: Article

References (51)

1. Balasch J, Miré F, Burzaco I et al. 1995 The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrohic hypogonadism and using recombinant human follicle stimulating hormone. Human Reproduction 10, 1678-1683.
2. Balasch J, Peñarrubia J, Fábregues F et al. 2003 Ovarian responses to recombinant FSH or HMG in normogonadotropic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction. Reproductive BioMedicine Online 7, 35-42.
3. Barbieri RL, Hornstein MD 1999 Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues. Endocrine Reviews 20, 249-252.
4. Ben-Amor A-F, on behalf of the Study Group 2000 The effect of luteinizing hormone administered during the late follicular phase in normo-ovulatory women undergoing in-vitro fertilization. Human Reproduction 15 (Abstract Book 1), 46.
5. Chappel SC, Howles C 1991 Re-evaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Human Reproduction 6, 1206-1212.
6. Couzinet B, Lestrat N, Brailly S et al. 1988 Stimulation of ovarian follicular maturation with pure follicle stimulating hormone in women with gonadotropin deficiency. Journal of Clinical Endocrinology and Metabolism 66, 552-556.
7. Daya S 2001 Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete infrafallopian transfer cycles (Cochrane Review). In: The Cochrane Library Issue 4. Oxford: Update Software.
8. Daya S 2003 Pitfalls in the design and analysis of efficacy trials in subfertility: Associate editor's commentary: on the article 'Common statistical errors in the design and analysis of subfertility trials' by A. Vail and E. Gardner. Human Reproduction 18, 1005-1009.
9. De Moustier B, Brinsen P, Bungum L et al. 2002 The effects of combined treatment of recombinant (r) FSH and r-hLH in ratios 1:1, 2:1 and 3:1 in women aged 38-42 years undergoing IVF-ICSI treatment. Human Reproduction 17 (Abstract Book 1), 55.
10. de Mouzon J, Rossin-Amar B, Bachelot A et al. 1998 FIVNAT. Influence of attempt rank in in fertilization. Contraception, Fertilité, Sexualité 26, 466-472.
11. De Placido G, Alviggi C, Mollo A et al. 2000 Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone. Human Reproduction 15, 17-20.
12. Fábregues F, Balasch J, Creus M et al. 1998 Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program. Fertility and Sterility 70, 46-51.
13. Filicori M, Cognigni GE 2001 Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction. Journal of Clinical Endocrinology and Metabolism 86, 1437-1441.
14. FIVNAT 1999 Dossier FIVNAT 1999. Bilan de l'anné 98.
15. FIVNAT 2000 Dossier FIVNAT 2000. Bilan de l'anné 99.
16. Fleming R, Chung CC, Yates RWS et al. 1996 Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophin, dependent upon the route of administration and endogenous luteinizing hormone activity. Human Reproduction 11, 1854-1858.
17. Fleming R, Lloyd F, Herbeert M et al. 1998 Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocytes and embryo function in cycles stimulated with purified follicle stimulating hormone. Human Reproduction 13, 1788-1792.
18. Golan A, Ron-El R, Herman A, Weinraub Z, Soffer Y, Caspi E 1989 Ovarian hyperstimulation syndrome: an update review. Obstetrical and Gynecological Survey 44, 430-440.
19. Hillier SG 1994 Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Human Reproduction 9, 188-191.
20. Hillier SG 2001 Gonadotropic control of ovarian follicular growth and development. Molecular and Cellular Endocrinology 179, 39-46.
21. Imthurn B, Macas E, Rosselli et al. 1996 Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin. Human Reproduction 11, 2387-2391.
22. Laml T, Obruca A, Fischl F et al. 1999 Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women. Gynecological Endocrinology 13, 98-103.
23. le Cotonnec JY, Loumaye E, Porchet HC et al. 1998 Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone. Fertility and Sterility 69, 201-209.
24. Lisi F, Rinaldi L, Fishel S et al. 2001 Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reproductive BioMedicine Online 3, 190-194.
25. Lisi F, Rinaldi L, Fishel S et al. 2002 Use of recombinant LH in a group of unselected IVF patients. Reproductive BioMedicine Online 5, 104-108.
26. Loumaye E, Engrand P, Howles CM et al. 1997 Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization outcome. Fertility and Sterility 67, 889-899.
27. Loumaye E, Engrand P, Shoman Z et al. 2003 Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Human Reproduction 18, 314-322.
28. Marcus SF, Edwards RG 1994 High rates of pregnancy after long-term down-regulation of women with severe endometriosis. American Journal of Obstetrics and Gynecology 171, 812-817.
29. Meo F, Rainieri DM, Khadum I et al. 2002 Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin. Fertility and Sterility 77, 630-632.
30. O'Dea L St L and The US Recombinant LH Study Group 2000 Recombinant LH in support of recombinant FSH in female hypogonadotropic hypogonadism - evidence of threshold effects (abstract). Fertility and Sterility 74 (supp. 3), S36.
31. Olivennes F, Righini C, Fanchin R et al. 1996 A protocol using a low dose of gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3. Human Reproduction 11, 1169-1172.
32. Phelps JY, Figueira-Armada L, Levine AS et al. 1999 Exogenous luteinizing hormone (LH) increases estradiol response patterns in poor responders with low serum LH concentrations. Journal of Assisted Reproduction and Genetics 16, 363-368.
33. Pieters MHEC, Dumoulin JCM, Engelhart CM et al. 1991 Immaturity and aneuploidy in human oocytes after different stimulation protocols. Fertility and Sterility 56, 306-310.
34. Practice Committee of the American Society for Reproductive Medicine 2002 Aging and infertility in women: a committee opinion. Fertility and Sterility 78, 215-219.
35. Rao CV 2001 Multiple novel roles of luteinizing hormone. Fertility and Sterility 76, 1097-1100.
36. Ravhon A, Aurell R, Lawrie H et al. 2000 The significance of delayed suppression using buserelin acetate and recombinant follicle-stimulating hormone in a long protocol in vitro fertilisation program. Fertility and Sterility 73, 325-329.
37. Schroor DC, van Weissenbruch M, Engelbert M et al. 1999 Bioactivity of luteinizing hormone during normal puberty in girls and boys. Hormone Research 51, 230-237.
38. Shemesh M 2001 Actions of gonadotrophins on the uterus. Reproduction 121, 835-842.
39. Shoham Z 2002 The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertility and Sterility 77, 1170-1177.
40. Speroff L 1993 Aging and reproduction. Postgraduate Obstetrics and Gynecology 13, 1-5.
41. Sullivan MW, Stewart-Akers A, Krasnow JS et al. 1999 Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation. Journal of Clinical Endocrinology and Metabolism 84, 228-32.
42. Surrey ES, Schoolcraft WB 2000 Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertility and Sterility 73, 667-676.
43. Tan SL, Doyle P, Maconochie N et al. 1994 Pregnancy and birth rates of live infants after in vitro fertilization in women with and without previous in vitro fertilization pregnancies: a study of eight thousand cycles at one center. American Journal of Obstetrics and Gynecology 170, 34-40.
44. Templeton A, Morris JK 1998 Reducing the risk of multiple births by transfer of two embryos after in vitro fertilisation. New England Journal of Medicine 339, 573-577.
45. Templeton A, Morris JK, Parslow W 1996 Factors that affect outcome of in vitro fertilisation treatment. Lancet 348, 1402-1406.
46. Tesarik J, Mendoza C 2002 Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Human Reproduction 17, 3129-3137.
47. Veeck L 1990 The morphological assessment of human oocytes and early concepti. In: Keel BA, Webster VW (eds) Handbook of the Laboratory Diagnosis and Treatment of Infertility. CRC Press, Boca Ratón, pp. 353-369.
48. Westergaard LG, Laursen SB, Andersen YC 2000 Increased risk of early pregnancy loss by profound suppresion of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Human Reproduction 15, 1003-1008.
49. Westergaard LG, Erb K, Laursen SB, Rex S, Rasmussen PE 2001 Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. Fertility and Sterility 76, 543-549.
50. Yim SF, Lok IH, Cheung, LP et al. 2001 Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF. Human Reproduction 16, 492-494.
51. Zeleznik AJ 2001. Follicle selection in primates: 'Many are called but few are chosen'. Biology of Reproduction 65, 655-659.